Allied Market Research

2024

Antithrombotic Drugs Market

Antithrombotic Drugs Market Size, Share, Competitive Landscape and Trend Analysis Report, by Indication, by Drug Class, by Route of Administration and, by Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Antithrombotic drugs help to prevent thrombus or blood clots from forming. These medicines used to reduce the formation of blood clots by reducing the body's ability to form blood clots. These drugs act by preventing the production of vitamin K in the liver. Antiplatelet, anticoagulant, and thrombolytic drugs are different types of antithrombotic drugs that work through different clotting processes. Arterial thrombosis and venous thrombosis are the different types of thrombosis which can be treated with use of antithrombotic drugs. Aspirin, Heparins, Vitamin K Antagonists, Glycoproteins, and Direct Thrombin Inhibitors are some drugs which are used as anti-thrombotic drugs.

COVID-19 Impact Analysis             

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the antithrombotic drugs market.

Top Impacting Factors

  • Surge in prevalence of chronic diseases, increase in geriatric population, rise in demand of targeted disorder treatment procedures, increase in thrombotic events, surge in number of genetic disorders, and rise in awareness regarding treatment of blood clot are the key factors that drive the growth of market.
  • In addition, surge in expenses on healthcare sector, rise in peoples suffering from obesity & cardio vascular problems, effectiveness & advantages associated with usage of antithrombotic drugs such as effective arterial circulation, increase in demand of minimally invasive treatment procedures, and rise in usage of targeted drug therapies are some factors that boost the growth of market.
  • However, serious adverse effects of this drug and incompatibility with pregnant women hinder the growth of market.
  • Contrarily, growth opportunities in emerging markets is expected to offer lucrative opportunities for the expansion of the market.

Market Trend

New Product Launches to Flourish the Market

In 2021, Valeo Pharma announced launch of its Redesca antithrombotic drug. This drug is low molecular weight heparin and can be used in treatment of blood clots.

In 2020, Natco announced launch of drug named as Rivaroxaban. This product can be used as anticoagulant drug to prevent blood clots. This drug sold under brand name Xarelto in Indian Market.

Key Benefits of the Report

  • This study presents the analytical depiction of antithrombotic drugs market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Antithrombotic Drugs Market Report             

  • Which are the leading players active in the antithrombotic drugs market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "antithrombotic drugs "?
  • What is "antithrombotic drugs" market prediction in the future?
  • Who are the leading global players in the "antithrombotic drugs" market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "antithrombotic drugs" market report?

Antithrombotic Drugs Market Report Highlights

Aspects Details
icon_5
By Indication
  • Pulmonary Embolism
  • Deep Vein Thrombosis
  • Atrial Fibrillation
  • Others
icon_6
By Drug Class
  • Thrombolytic Drugs
  • Anti-Platelet Drugs
  • Anticoagulants
  • Others
icon_7
By Route of Administration
  • Oral
  • Injectable
icon_8
By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_10
Key Market Players

Dr. Reddy’s Laboratories, Pfizer Inc., Sanofi, Johnson and Johnson Services Inc., The Medicines Company, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Genentech Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Antithrombotic Drugs Market

Global Opportunity Analysis and Industry Forecast, 2023-2032